Skip to main content
Fig. 9 | Journal of Nanobiotechnology

Fig. 9

From: Application of fluorocarbon nanoparticles of 131I-fulvestrant as a targeted radiation drug for endocrine therapy on human breast cancer

Fig. 9

In vivo antitumor efects of 131I-fulvestrant-ALA-PFP-FA-NPs: A Evaluation of in vivo antitumor effects in different drug treatment groups: changes in tumor size following different treatments. B Growth curves of tumors in different drug treatment groups following various treatments. C Survival curves of tumor-bearing mice in different drug treatment groups following various treatments. D Histological evaluation of tumor tissues in different drug treatment groups: he staining, Ki67 staining, and TUNEL staining. a: PBS, b: Fulvestrant, c: 131I-fulvestrant, d: 131I-fulvestrant-PFP-NPs,e: 131I-fulvestrant-PFP-FA-NPs, f: 131I-fulvestrant-ALA-PFP-FA-NPs(Scale bar represents 50 μm for all panels, Values are Mean ± S.D., n = 5)

Back to article page